Investigational Site Number :8400010

Philadelphia, Pennsylvania 19104

0 studies enrolling now · 3 studies all time

What they study most

COVID-19, Microvascular Coronary Artery Disease, Neurodermatitis

Studies at this site

• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME) — Completed
• Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older — Stopped early
• A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI — Stopped early